← All trials
NCT04563754
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 30, 2019
- Primary completion
- Mar 28, 2023
- Completion date
- Mar 28, 2023
- First posted
- Sep 24, 2020
- Last posted
- Jul 20, 2023
- Enrollment
- 161
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Baylor UniversityLead sponsor
- Baylor UniversityOverall official - principal investigator
- Baylor UniversityReponsible party - principal investigator
- Icahn School of Medicine at Mount SinaiCollaborator
- University of Texas at HoustonCollaborator
- University of Texas at HoustonOverall official - principal investigator
- Medical University of South CarolinaCollaborator
- University of Texas at HoustonCollaborator
- University of California, San FranciscoCollaborator
- William Marsh Rice UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.